Dergiler / Marmara Medical Journal / 2023 / Cilt: 36 - Sayı: 1

Effect of troponin I and coagulation parameters on mortality in COVID-19 patients

Sayfa
135–139
Yayın Tarihi
2023-01-31
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Measurements of troponin-I and coagulation markers such as D-dimer, fibrinogen and INR can help predict clinical severity and mortality in COVID-19 patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Our aim is to determine the levels of troponin-I and some coagulation markers (D-dimer, fibrinogen and International Normalized Ratio (INR)) in coronavirus disease 2019 (COVID-19) patients and to investigate the effects of these markers on mortality.
📊
Temel Bulgular & Veri:The study was conducted by retrospectively scanning the files of COVID-19 patients who applied to Inonu University Turgut Ozal Medical Center between 01.03.2020 and 31.12.2020.
💡
Sonuç & Katkı:Conclusion: Measurements of troponin-I and coagulation markers such as D-dimer, fibrinogen and INR can help predict clinical severity and mortality in COVID-19 patients.
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:COVID-19 · Troponin I · Coagulation markers

Abstract

Objective: Our aim is to determine the levels of troponin-I and some coagulation markers (D-dimer, fibrinogen and International Normalized Ratio (INR)) in coronavirus disease 2019 (COVID-19) patients and to investigate the effects of these markers on mortality. Patients and Methods: It is planned as a descriptive, cross-sectional and analytical study. The study was conducted by retrospectively scanning the files of COVID-19 patients who applied to Inonu University Turgut Ozal Medical Center between 01.03.2020 and 31.12.2020. Levels of cardiac troponin I markers and coagulation parameters (D-dimer, fibrinogen and INR) were detected. Results: The results of a total of 1858 patients were obtained. One thousand, three hundred and twenty-six patients with only troponin I and D-dimer results (Group 1), 606 patients with only troponin I and fibrinogen results (Group 2), and 1308 patients with only troponin I and INR results (Group 3) were included. Troponin I levels were significantly higher in all patients who died. 96.6% of the patients with high D-dimer levels died in Group 1, 85.5% of the patients with high fibrinogen levels died in Group 2 and 77.3 % of the patients with high INR levels died in Group 3. Conclusion: Measurements of troponin-I and coagulation markers such as D-dimer, fibrinogen and INR can help predict clinical severity and mortality in COVID-19 patients.

🔖

Bu Makaleye Atıf Yap

DAG, M., BULUT, N., TASKAPAN, M. C. (2023). Effect of troponin I and coagulation parameters on mortality in COVID-19 patients. Marmara Medical Journal, Cilt: 36 - Sayı: 1, 135–139. https://ajindex.com/articles/880015

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

  1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323:1239-42. doi: 10.1001/jama.2020.2648. Gülbahar M, Gök MZ. Koronavirüs-19'un Kardiyovasküler Sistem Üzerine Etkileri. Turkiye Klinikleri J Nurs Sci 2020; 12:305-14. doi:10.5336/nurses.2020-75550.
  2. Gemalmaz H, Gültekin Y, Kural T. Açık kalp cerrahisinde 72 saatlik trimetazidin uygulamasının miyokard iskemisi üzerine etkileri. Kırıkkale Uni Med J 2021; 23:49-58. doi: 10.24938/kutfd.824624. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18:844-7. doi: 10.1111/jth.14768. Srivastava S, Garg I, Bansal A, Kumar B. COVID-19 infection and thrombosis. Clinica Chimica Acta 2020; 510:344-6. doi: 10.1016/j.cca.2020.07.046. Wang Y, Shu H, Liu H, et al. The peak levels of highly sensitive troponin I predicts in-hospital mortality in COVID-19 patients with cardiac injury: a retrospective study. Eur Heart J Acute Cardiovasc Care 2021; 10: 6-15. doi: 10.1093/ehjacc/zuaa019. Xiong TY. Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J 2020; 41:1798-800. doi: 10.1093/eurheartj/ehaa231. Li C, Jiang J, Wang F, et al. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients. J Mol Cell Cardiol 2020; 147:74-87. doi: 10.1016/j.yjmcc.2020.08.008. Singh S, Chowdhry M, Chatterjee A, Khan A. Gender-based disparities in COVID-19 patient outcomes: A propensity-matched analysis. medRxiv 2020:2020.04.24.20079046. doi: 10.1101/2020.04.24.20079046. Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020; 584(7821):430-6. doi:10.1038/s41586-020-2521-4.
  3. Chen TL, Dai Z, Mo P, et al. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: A single-centered, retrospective study. J Gerontol A Biol Sci Med Sci Series A 2020; 75:1788–95, doi: 10.1093/gerona/glaa089. Li P, Chen L, Liu Z, et al. Clinical features and short-term outcomes of elderly patients with COVID-19. Int J Infect Dis 2020; 97:245-50. doi: 10.1016/j.ijid.2020.05.107. Stefanini GG, Chiarito M, Ferrante G, et al. Earl